TP53 and lung cancer: To investigate the effect of AURKA inhibition on cell proliferation, cell survival after MLN8237 treatment was analyzed in three selected cultured human lung cancer cell lines, the P53-competent cell lines H460 and HCC2429, and the P53-deficient cell line H1299.